Maria Palasis - 18 Mar 2024 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
President & CEO, Director
Signature
/s/ Jason Cavalier, Attorney-in-Fact for Maria Palasis, Ph.D.
Issuer symbol
LYRA
Transactions as of
18 Mar 2024
Net transactions value
$0
Form type
4
Filing time
20 Mar 2024, 19:20:58 UTC
Previous filing
12 Jul 2023
Next filing
18 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LYRA Stock Option Award $0 +500,000 $0.000000 500,000 18 Mar 2024 Common Stock 500,000 $5.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 31, 2024.